A b s t r a c t
The spectrum of soft tissue tumors demonstrating myofibroblastic differentiation encompasses reactive proliferations and benign and malignant neoplasms. 1 Although the precise identification of a myofibroblast requires ultrastructural examination, in practice, most pathologists recognize myofibroblasts based on their light microscopic appearance and appropriate immunohistochemical staining profile. 1, 2 Since the latter exhibits extensive overlap with the immunohistochemical staining profile of smooth muscle cells, this may lead to imprecise classification of spindle cell tumors. 3 In our experience, the differentiation of myofibroblasts from smooth muscle cells remains problematic in tumor pathology. The standard panel of antibodies directed against "myoid" antigens (desmin, muscle actin, smooth muscle actin) that is used in the workup of spindle cell soft tissue tumors does not reliably allow this distinction. 3 Recent data suggest that a new commercially available antibody directed against high-molecular-weight caldesmon (h-caldesmon) labels cells with true smooth muscle cell morphologic features in a more specific manner than previously available antibodies. 4, 5 The purpose of the present study was to document the staining reaction of anti-h-caldesmon with a variety of myofibroblastic and true smooth muscle tumors. In addition, all of the examined tumors also were studied using the aforementioned panel of the standard conventional myoid markers. sarcoma (4 cases), malignant peripheral nerve sheath tumor (5 cases), and leiomyosarcoma (11 cases) were obtained from the surgical pathology files of the Vancouver General Hospital, Vancouver, British Columbia. Cases of infiltrating breast carcinoma with surrounding desmoplastic stroma (5 cases) and acute cholecystitis with a reactive myofibroblastic response (5 cases) were similarly obtained. The diagnostic criteria used for each of the tumors and tumor-like lesions are as follows:
1. Fibromatosis: a soft tissue tumor deep to the fascia composed of intersecting fascicles of spindle cells embedded in a richly collagenized background. The fascicles demonstrate numerous thin-walled capillaries. Individual cells have uniform elongate spindled nuclei with vesicular chromatin and readily visible small nucleoli. Mitotic figures are infrequent ❚Image 1❚.
2. Nodular fasciitis: a cellular soft tissue tumor present within the subcutaneous tissue. The mass is focally well circumscribed and associated with an organized collagenous (fascial) layer. There is architectural variability with cells arranged as sheets, fascicles, and storiform arrays and, at least focally, a haphazard distribution within a capillary-rich ground substance (tissue culture-like). Cytologically, the lesional cells exhibit plump oval to spindled nuclei, vesicular chromatin, and, frequently, large nucleoli. The cells have readily visible eosinophilic cytoplasm. Mitotic figures are seen readily ❚Image 2❚.
3. Cellular cutaneous fibrous histiocytoma: a dermalbased cellular spindle cell tumor measuring less than 2.0 cm with or without focal extension into the subcutaneous fat. The tumor cells are arranged as sheets, storiform arrays, and intersecting fascicles. At the center of the tumor, the dermal collagen pattern is obliterated. The lateral edges of the mass are poorly defined and contain hyalinized collagen bundles. 6. Synovial sarcoma: a monophasic or biphasic spindle and/or epithelioid cell sarcoma. The lesional spindle cells demonstrate relatively uniform nuclei and a scant tapering cytoplasmic process. The lesional cells are arranged as sheets and fascicles and commonly are associated with dense eosinophilic collagen. Marked nuclear pleomorphism is not a feature of these tumors. Biphasic neoplasms have, in addition to the characteristics of synovial sarcomas, true glands and tubules, often with eosinophilic luminal contents.
7. Malignant peripheral nerve sheath tumor: a variably cellular spindle cell sarcoma composed of sheets and fascicles of spindle cells with hyperchromatic wavy nuclei. Mitoses are found readily, and these tumors typically demonstrate varying cellularity and nuclear pleomorphism. In practice, at the time of diagnosis these tumors demonstrated origin from a peripheral nerve, occurred in patients with neurofibromatosis, or both.
Reactive myofibroblastic proliferations representing the supporting stroma in conventional infiltrating ductal carcinoma of the breast and the subserosal spindle cell proliferation on the surface of acutely inflamed gallbladders also were examined.
Immunohistochemical Methods
Immunohistochemical stains were performed with an avidin-biotin-peroxidase complex and a Ventana ES automated immunostainer (Ventana Medical Systems, Tucson, ❚Image 1❚ Fascicles of cellular collagen-rich fibromatosis (H&E, ×200).
❚Image 2❚ Cellular focus of nodular fasciitis demonstrating poorly formed storiform arrays (H&E, ×200).
❚Image 3❚ The deep aspect of a cellular cutaneous fibrous histiocytoma demonstrating the intense cellularity, mild atypia and focal fascicular growth (H&E, ×200).
❚Image 4❚ High-grade malignant fibrous histiocytoma demonstrating storiform growth and focal tumor giant cells (H&E, ×200). AZ) using the antibodies listed in ❚Table 1❚ and a 32-minute incubation period. Sections stained with anti-h-caldesmon or anti-desmin underwent heat-induced epitope retrieval before staining. The deparaffinized slides were sealed in a container containing citrate buffer and placed in a pressure cooker. These slides were then microwaved on high and allowed to boil for 4 minutes and to sit for 20 minutes. The slides were cooled under running distilled water. Sections of leiomyoma were used as positive controls, and sections of synovial sarcoma were used as negative controls.
Results
Positive staining was scored on a 0 to 3+ scale based on the percentage of tumor cells stained in each lesion (0, no staining; 1+, <25% of cells; 2+, 25%-75% of cells; and 3+, >75% of cells). The staining results are summarized in ❚Table 2❚. Briefly, 10 of 11 leiomyosarcomas were labeled diffusely with antibodies to h-caldesmon. In these cases, more than 99% of the tumor cells typically were labeled ❚Image 6❚. In 1 case, the staining was focal, involving less than 25% of the tumor cells. This tumor (case 7) was a grade 3/3 sarcoma that had been irradiated before resection, and the tumor cells demonstrated marked nuclear degenerative changes suggestive of irradiation effect. In addition, the other muscle markers (desmin, smooth muscle actin, and muscle actin) also stained the tumor cells in a more focal manner than in the remainder of the cases, suggesting that antigen preservation in this sample may have been suboptimal.
In 2 of the leiomyosarcomas, there was an abrupt transition between conventional leiomyosarcoma and undifferentiated MFH-like sarcoma. We classified these tumors as "dedifferentiated leiomyosarcomas" and noted that the positive staining for h-caldesmon was restricted to the regions of morphologically typical leiomyosarcoma only ❚Image 7❚.
Anti-h-caldesmon failed to stain any cells in the cases of nodular fasciitis, fibromatosis, synovial sarcoma, or malignant peripheral nerve sheath tumor or in the desmoplastic stroma or reactive myofibroblasts in the cases of infiltrating breast carcinoma and acute cholecystitis, respectively. There was focal staining of less than 1% of the lesional cells in 3 of the MFHs ❚Image 8❚ and 1 of the cellular cutaneous fibrous histiocytomas. As outlined in Table 2 , there was staining for 1 or more of the other myoid markers in 11 of 26 MFHs, 11 of 11 fibromatoses, 4 of 4 cases of nodular fasciitis, and 7 of 11 cellular cutaneous fibrous histiocytomas. Although, in general, this staining was focal (compared with the diffuse staining seen in leiomyosarcoma), in many cases the staining for anti-smooth muscle actin and muscle actin affected the majority of the cells in a single region ❚Image 9❚ and ❚Image 10❚.
Staining for desmin occasionally exhibited this appearance, particularly in cases of fasciitis and fibromatosis, whereas in cellular cutaneous fibrous histiocytoma, it was typically present in more dispersed cells ❚Image 11❚. The desmoplastic stroma in 5 of 5 infiltrating breast carcinomas and myofibroblastic reaction in 5 of 5 cases of acute cholecystitis also exhibited focal or diffuse staining with 1 or more myoid markers.
Discussion
Myofibroblasts demonstrate morphologic features intermediate between fibroblasts and smooth muscle cells. 2 In addition to the overlap that exists at the level of light microscopy, myofibroblasts and smooth muscle cells also demonstrate overlapping immunohistochemical staining profiles using antibodies to actin, smooth muscle actin, and desmin. 1, 3 The 2 cell types can be distinguished ultrastructurally 2 ; however, in practical terms, the limited availability of diagnostic electron microscopy facilities hinders the usefulness of this technique in surgical pathology. Under "normal" circumstances, myofibroblasts occur in granulation tissue and healing scars. 2 Cells exhibiting myofibroblastic morphology have been recognized as the principal cellular com-ponent of numerous soft tissue tumors, including nodular fasciitis, mammary myofibroblastoma, dermatomyofibroma, intranodal myofibroblastoma, fibromatoses, low-grade myofibroblastic sarcoma, and many others. 1, 6 In addition, tumors classified as so-called MFH frequently demonstrate ultrastructural features of various subtypes of fibroblasts, including myofibroblasts. 7 In our experience, precise classification of spindle cell soft tissue tumors is frequently troublesome, and positive immunohistochemical staining for muscle actin, smooth muscle actin, and/or desmin is interpreted mistakenly, not uncommonly, as representing evidence of smooth muscle differentiation. Anti-h-caldesmon, by being a more specific identifier of smooth muscle differentiation, potentially would be helpful in this regard by allowing appropriate classification of spindle cell tumors exhibiting myofibroblastic or smooth muscle differentiation.
Caldesmon is a cytoskeleton-associated protein present in smooth and non-smooth muscle cells. [8] [9] [10] [11] Leiomyosarcoma  1  3+  3+  3+  3+  2  3+  3+  3+  3+  3  3+  3+  3+  3+  4  3+  3+  3+  3+  5  3+  3+  3+  3+  6  3+  2+  3+  3+  7  1+  2+  1+  2+  8  3+  3+  3+  3+  9  3+  3+  3+  3+  10 *  3+  3+  3+  3+  11 *  3+  3+  3+  3+  MFH  1 1  0  1+  0  1+  2  0  1+  1+  1+  3  0  1+  1+  2+  4  0  1+  1+  2+  5  0  1+  1+  1+  6  0  1+  1+  1+  7  0  0  0  1+  8  0  1+  1+  1+  9  0  0  1+  1+  10  0  1+  0  1+  11  0  0  1+  2+  Nodular fasciitis  1  0  0  2+  3+  2  0  0  0  3+  3  0  0  0  2+  4  0  0  1+  3+  CCFH  1  0  0  0  1+  2  0  1+  1+  1+  3 of cellular contraction. [8] [9] [10] [11] High-and low-molecular-weight forms of the protein occur. 8, 9 The high-molecular-weight form is thought to be restricted to smooth muscle and myoepithelial cells. 5 There have been few studies of the expression of h-caldesmon in soft tissue tumors. Watanabe et al 4 demonstrated that h-caldesmon expression was limited to soft tissue neoplasms demonstrating smooth muscle differentiation. Leiomyomas, angioleiomyomas, leiomyosarcomas, and glomus tumors were consistently diffusely and strongly positive for anti-h-caldesmon, whereas MFHs, inflammatory myofibroblastic tumors, desmoid tumors, and a variety of myoepithelial-type neoplasms were consistently negative. 4 These investigators noted extensive staining in all tumors tested for antibodies directed against actin (HHF35) and smooth muscle actin, 4 as we did. Two of 8 gastrointestinal stromal tumors tested also exhibited positive staining for hcaldesmon. Watanabe et al 4 concluded ". . . that h-caldesmon can be used as a specific marker of smooth muscle cells and tumors originating from smooth muscle cells." Miettinen et al 5 reported very similar results, demonstrating h-caldesmon staining in 96% of 90 examined visceral and soft tissue tumors demonstrating smooth muscle differentiation. Four of 31 retroperitoneal leiomyosarcomas were the only smooth muscle tumors that failed to stain positively. 5 On the other hand, 6 cases of nodular fasciitis and 10 desmoid tumors failed to demonstrate positive staining. 5 Miettinen et al 5 recorded focal staining involving less than 10% of tumor cells in 11 of 15 tumors classified as MFH and in the dedifferentiated regions of dedifferentiated liposarcoma in 6 of 10 tumors. In contrast, these investigators noted that positive staining for h-caldesmon was restricted to the well-differentiated component of several examined uterine leiomyosarcomas. 5 Overall, these results are rather similar to our own. As both of these groups of investigators have described, anti-h-caldesmon typically stains the vast majority of cells in smooth muscle tumors. 4, 5 We also noted focal positive staining in fewer than 1% of tumor cells in 3 of 26 MFHs and in 1 of 11 cellular cutaneous fibrous histiocytomas in our study group. Although we found diffuse positive staining in 10 of 11 tumors classified ❚Image 6❚ Diffuse cytoplasmic staining for h-caldesmon in virtually every cell of this leiomyosarcoma (×200). as conventional leiomyosarcoma, in 2 of the tumors in our series, there was an abrupt transition between conventional leiomyosarcoma and undifferentiated MFH-like sarcoma (tumors that we classified as "dedifferentiated leiomyosarcomas"). In these tumors, positive staining was restricted to the morphologically typical leiomyosarcoma. It has become increasingly clear that MFH, despite its name, typically lacks definite histiocytic differentiation and, in practical terms, MFH is a diagnosis of exclusion. 12, 13 To this end, the more histogenetically apt designations of "undifferentiated spindle cell sarcoma" or "sarcoma not otherwise specified" may be more appropriate for these tumors. The percentage of high-grade sarcomas classified as MFH seems to be inversely proportional to the effort with which "alternative lines of differentiation" are sought. Our experience with high-grade soft tissue sarcomas of adult❚Image 8❚ Rare h-caldesmon-stained cells in one of the tumors classified as malignant fibrous histiocytoma. This was the field with the greatest number of positively stained cells. Most cells in this tumor were not stained by anti-hcaldesmon (×200).
❚ Image 9❚ Nodular fasciitis demonstrating diffuse intense staining (smooth muscle actin, ×200).
❚Image 10❚ Fibromatosis with strong staining (smooth muscle actin, ×200). hood is that a sizable number fail to show definite lineage differentiation. In fact, this group represents the most frequent high-grade sarcoma seen in our practice, accounting for the large representation in this study. We readily acknowledge that other pathologists may have classified some of the MFHs in our study group as other types of highgrade sarcoma; however, the cases that we have used fulfill the diagnostic criteria outlined in the "Methods" section. Nevertheless, based on the results of our staining and the findings of Miettinen et al, 5 it could be argued that indeed a proportion of so-called MFHs may best be classified as poorly differentiated leiomyosarcomas or, at least as Miettinen et al 5 propose, that the staining suggests ". . . their smooth muscle differentiation."
Anti-h-caldesmon may indeed help to further elucidate the nature of some of the tumors currently classified as MFH; however, we believe that the real usefulness of this antibody in diagnostic surgical pathology relates to its ability to distinguish myofibroblasts from smooth muscle cells in settings other than obvious high-grade soft tissue sarcomas. In this regard, anti-h-caldesmon provides particular help in the distinction of cellular cutaneous fibrous histiocytoma, fibromatosis, and nodular fasciitis from low-grade leiomyosarcoma, a not uncommon differential diagnostic challenge. One of the 11 tumors that we classified as a cellular cutaneous fibrous histiocytoma showed rare positive tumor cells, suggesting that scattered cells within these lesions may exhibit a more functionally complete smooth muscle phenotype (similar to a situation with poorly differentiated sarcomas such as MFH). The focal presence of an individual positively stained cell within myofibroblastic lesions should not be completely unexpected in the setting of a neoplasm in which cells may show a range of phenotypic differentiation. We believe that immunohistochemical staining with anti-hcaldesmon considerably aids in the distinction of smooth muscle cell neoplasms from myofibroblastic tumors and that it has a role as part of an immunohistochemical panel used in the examination of selected soft tissue tumors.
